Year archive

GenFleet Therapeutics (Shanghai) Inc. — 2025 filings

All 59 regulatory filings released by GenFleet Therapeutics (Shanghai) Inc. (2595) in 2025, sourced directly from the official regulator.

59 Filings

2025 Period

2025 filings (59)

Filing	Released	Lang
Notice of Annual General Meeting Proxy Solicitation & Information Statement	2025-12-18	English
Form of Proxy for the Annual General Meeting to be held on Tuesday, 20 January 2026 Proxy Solicitation & Information Statement	2025-12-18	English
(1) Renewal of General Mandates to Issue New Shares and Repurchase Shares; (2) Re-election of Retiring Directors; and (3) Notice of Annual General Meeting Proxy Solicitation & Information Statement	2025-12-18	English
Annual Report 2025 Annual Report FY 2025	2025-12-18	English
Final Dividend for the year ended 30 September 2025 Notice of Dividend Amount	2025-12-15	English
Final Results Announcement For The Year Ended 30 September 2025 Annual Report FY 2025	2025-12-15	English
VOLUNTARY ANNOUNCEMENT First Site Initiated in a Registrational Study of GFH375 for Metastatic Pancreatic Cancer, as First-in-world Phase III Monotherapy Study of an Oral KRAS G12D Inhibitor versus Ch Regulatory Filings	2025-12-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2025 Regulatory Filings	2025-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Share Issue/Capital Change	2025-12-01	English
PROPOSED ADOPTION OF THE H SHARE OPTION SCHEME AND THE H SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-11-24	English
Date of Board Meeting Report Publication Announcement	2025-11-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025 Share Issue/Capital Change	2025-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-03	English
VOLUNTARY ANNOUNCEMENT First Patient Dosed in a Phase Ib/II Study of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, Combined with Cetuximab or Chemotherapy for Advanced Solid Tumors including Regulatory Filings	2025-10-22	English
ARTICLES OF ASSOCIATION Governance Information	2025-10-21	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION Share Issue/Capital Change	2025-10-21	English
Next Day Disclosure Return Share Issue/Capital Change	2025-10-21	English
VOLUNTARY ANNOUNCEMENT EFFICACY DATA OF GFH375, AN ORAL KRAS G12D (ON/OFF) INHIBITOR, FOR PANCREATIC DUCTAL ADENOCARCINOMA PATIENTS PRESENTED AS A LATE-BREAKING ABSTRACT IN AN ORAL PRESENTATION A Regulatory Filings	2025-10-20	English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Share Issue/Capital Change	2025-10-16	English
Notification Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-10-15	English
Notification Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-10-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025 Capital/Financing Update	2025-10-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-30	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED WITH GFH276, A MOLECULAR GLUE PAN RAS (ON) INHIBITOR, IN A PHASE I/II STUDY TREATING RAS-MUTANT CANCER PATIENTS Regulatory Filings	2025-09-29	English
DATE OF BOARD RESOLUTIONS AND DATE OF PUBLICATION OF INTERIM REPORT Report Publication Announcement	2025-09-19	English
ANNOUNCEMENT OF ALLOTMENT RESULTS Share Issue/Capital Change	2025-09-18	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-09-18	English
Terms of Reference of the Nomination Committee of the Board of Directors Governance Information	2025-09-18	English
Terms of Reference of the Remuneration Committee of the Board of Directors Governance Information	2025-09-18	English
Terms of Reference of the Audit Committee of the Board of Directors Governance Information	2025-09-18	English
ARTICLES OF ASSOCIATION Governance Information	2025-09-18	English
Documents on Display Regulatory Filings	2025-09-11	English
GLOBAL OFFERING Share Issue/Capital Change	2025-09-11	English
GLOBAL OFFERING Share Issue/Capital Change	2025-09-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-01	English
PHIP (1st submission) Share Issue/Capital Change	2025-08-25	English
PHIP (1st submission) Audit Report / Information FY 2024	2025-08-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-02	English
OC Announcement - Appointment Regulatory Filings	2025-06-27	English
Application Proof (1st submission) Audit Report / Information FY 2024	2025-06-27	English
Application Proof (1st submission) Share Issue/Capital Change	2025-06-27	English
NOMINATION COMMITTEE - TERMS OF REFERENCE Governance Information	2025-06-16	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-06-16	English
APPOINTMENT OF MEMBER OF NOMINATION COMMITTEE Board/Management Information	2025-06-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-02	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-05-30	English
Interim Dividend for the six months ended 31 March 2025 Notice of Dividend Amount	2025-05-28	English
Interim Results Announcement for the Six Months Ended 31 March 2025 Interim / Quarterly Report H1 2025	2025-05-28	English
Positive Profit Alert Earnings Release H1 2025	2025-05-23	English
Date of Board Meeting Report Publication Announcement	2025-05-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-04	English
CHANGE OF HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE Regulatory Filings	2025-01-24	English
Poll Results of the Annual General Meeting Held on 20 January 2025 Declaration of Voting Results & Voting Rights Announcements	2025-01-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-02	English

Filings by year

2026 31 filings
2025 59 filings
2024 30 filings
2023 29 filings
2022 34 filings
2021 33 filings
2020 27 filings
2019 24 filings
2018 52 filings
2017 39 filings
2016 25 filings
2015 23 filings
2014 29 filings
2013 38 filings
2012 33 filings
2011 18 filings
2010 34 filings
2009 23 filings
2008 15 filings
2007 10 filings
2006 17 filings
2005 10 filings
2004 18 filings
2003 9 filings
2002 9 filings